DNA Genetics

What DNA Genetics does

DNA Genetics is a privately held, family-owned swine genetics company headquartered in Columbus, Nebraska, and the only independent, American-owned operation of its kind in the U.S. pork industry. The company develops and commercializes proprietary maternal and terminal pig genetics — most notably the DNA Line 241 Landrace x Yorkshire F1 maternal gilt and the DNA Line 600 purebred Duroc terminal boar — selected against American production economics rather than European or Asian benchmarks. Its genetic improvement program is anchored by a proprietary Helix database that records every phenotype on every animal, enabling genomic selection, individual feed-intake recording, and continuous nucleus testing across thousands of offspring per week.

The business operates a vertically integrated model: it maintains a 71,000-sow commercial herd that doubles as a real-world validation environment for its genetics while supplying two million full-program offspring for benchmarking. Revenue is generated primarily through direct sales of nucleus boars and high-health maternal gilts to commercial farrow-to-finish producers, supplemented by recurring technical services such as on-farm evaluations, farm-specific training, genetic indexing, nutrition consultation, and monthly benchmarking reports. DNA Genetics distributes through direct enterprise field sales and a self-serve DNA Easy Link customer portal, supported by producer education assets including the Inside the Helix podcast, the Beyond the Helix content library, and the biannual Research Report. The company is closely held under the Pillen family alongside Pillen Family Farms, with co-CEO leadership across Jim, Brock, and Sarah Pillen formalizing a generational transition.

Name

DNA Genetics

Legal name

DNA Genetics

Website

https://dnaswinegenetics.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

DNA Genetics is a family-owned, U.S.-based swine genetics company that breeds and sells proprietary maternal and terminal pig lines — DNA Line 241 and DNA Line 600 — directly to commercial farrow-to-finish pork producers, supported by on-farm technical services and the proprietary Helix database.

Ownership category

akta.pro rank

Product category

Swine Genetics

NAICS

Hog and Pig Farming (11221)

SIC

Agricultural Prod-Livestock & Animal Specialties (200)

akta.pro primary industry

Nucleus Herd/Flock Breeding & Multiplier Stock Supply (AFAEAJAF)

akta.pro secondary industries

Genomic Testing & Genetic Evaluation Services (AFAEAJAC), Genetic Testing & Genomic Profiling Services (Parentage, Trait Testing) (AFACAEAE)

Keywords

• Swine genetics
• Pig breeding stock
• Maternal pig lines
• Terminal boar lines
• Commercial pork genetics

Headquarters

HQ city

Columbus

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Swine Genetics Sales: Sale of DNA Genetics swine genetics including maternal line gilts (DNA Line 241 F1) and terminal line boars (DNA Line 600 Duroc). Boars are performance tested, genotyped, and sold directly from nucleus farms with guaranteed supply.
2. Technical Support Services: Technical support and account leadership services including on-farm support, written evaluations, farm-specific training, and monthly benchmarking reports.
3. Genetic Services: Genetic services including herd indexing, genetic lag reduction through on-farm visits, and monthly benchmarking reports to help producers realize maximum genetic potential.
4. Nutrition Consultation: Works with producers and their nutritionists to review and implement optimal feeding programs for DNA pigs. Collaborates with leading research institutions and nutrition partners.
5. Research Collaboration: Geneticists and statisticians engage with producers to design trials evaluating various performance factors that bring value to their systems.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

DNA Genetics is a swine genetics company that breeds and sells superior maternal and terminal pig lines to commercial pork producers. The company sells DNA Line 241 F1 maternal gilts (Landrace x Yorkshire), foundation purebred Yorkshire and Landrace lines, and the DNA Line 600 Duroc terminal boar line, supported by a proprietary genetic selection program that delivers genetic progress, feed efficiency, and sow productivity to farrow-to-finish operations.

Product overview

DNA Genetics is an independent, American-owned swine genetics company operating as a single unified platform. Their core product portfolio centers on the DNA Line 241 maternal line (Landrace x Yorkshire F1) and the DNA Line 600 Duroc terminal line, supported by foundational purebred lines (DNA Line 200 Yorkshire, DNA Line 400 Landrace). The genetic program is powered by their proprietary Helix database and includes genomic selection, commercial crossbred testing, and distribution of genetic potential from nucleus to customer. Additional offerings include customer support with access to their 71,000-sow commercial operation, the Easy Link customer portal, the Beyond the Helix educational content series, The Research Report publication, and the Inside the Helix podcast.

Differentiator

Problem solved

Functional benefit

Brands

• DNA Line 241: The DNA Line 241 is a Landrace x Yorkshire maternal line described as the Gold Standard, capable of weaning 32+ superior pigs per sow per year.
• DNA Line 600
• Inside the Helix
• Beyond the Helix

Products and services

• DNA Line 241 (Maternal Line) The gold-standard maternal line combining Landrace x Yorkshire genetics, proven to wean 32+ superior pigs per sow per year with heavy weaning weights and uniform litters. Sold as F1 maternal gilts to commercial pork producers running farrow-to-finish operations.

Quantifiable outcome

• 32+ superior pigs weaned per sow per year with uniformity through finishing
• +3 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• PIC (Pig Improvement Company) / Genus PIC: Operated by Genus plc (LSE: GNS), PIC is the world's largest swine genetics company with a global nucleus pyramid and direct competition in both maternal and terminal lines. It is DNA Genetics' most direct global competitor and the benchmark against which DNA Genetics positions its "American-independent" differentiation.
• Topigs Norsvin: European cooperative-based swine genetics company operating a global nucleus system and competing directly in the North American market. It is a leading alternative to DNA Genetics' maternal and terminal offerings, with comparable technology platforms and similar direct-sales models.
• Danbred: Danish swine genetics company with a globally distributed nucleus competing in the same maternal and terminal line categories as DNA Genetics. Its presence in North America makes it a head-to-head competitor for commercial U.S. pork producers, particularly those with European production heritage.
• Hypor (Hendrix Genetics): A Hendrix Genetics business unit focused on swine genetics with global nucleus operations and direct competition in the U.S. market. Comparable to DNA Genetics in delivering maternal and terminal lines to commercial pork producers through direct and channel sales.
• Axiom (Groupe Grimaud / Choice Genetics): Swine genetics line within Groupe Grimaud, formed from the merger of Choice Genetics and other Grimaud swine assets. Competes in the North American swine genetics market with comparable nucleus-based maternal and terminal programs.
• Fast Genetics (Genus-affiliated): North American swine genetics supplier operating within the Genus plc ecosystem alongside PIC. Offers maternal and terminal products that compete directly with DNA Genetics' Line 241 and Line 600, particularly in Canadian and U.S. commercial accounts.

Broad incumbents

• Smithfield Premium Genetics (Smithfield Foods / WH Group): The in-house swine genetics program of Smithfield Foods, the largest U.S. pork producer. While vertically integrated for internal supply, it represents a structural competitor — and a captive alternative — for any expansion of DNA Genetics' share with large integrators.
• Genus plc: UK-listed animal genetics company whose PIC division is the dominant global swine genetics franchise. Genus is the public-market benchmark for valuing a global swine genetics platform and competes with DNA Genetics through PIC and Fast Genetics in North America.

Emerging players

• Pillen Family Farms: DNA Genetics' parent/strategic operating company and the third-largest pork producer in the U.S. While a sister entity rather than a direct competitor, Pillen's commercial 71,000-sow operation is the integrated proving ground for DNA Genetics' genetic program and a model for nucleus-integrated-commercial swine businesses.

Regional players

• GenetiQ: Australian swine genetics provider operating in a different geography but with comparable nucleus-based program structure and direct-to-producer service model. Useful as a regional benchmark for how independent, single-country swine genetics businesses scale and compete against global players.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/dna_sw
• LinkedInlinkedin.com/company/dna-genetics

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DNA Genetics